Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma / Erratum. International Journal of Oncology, 45(6):2605.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. International Journal of Oncology, 44(6):1843-1852.

Bähr, O; Hermisson, M; Rona, S; Rieger, J; Nussbaumer, S; Körtvelyessy, P; Franz, K; Tatagiba, M; Seifert, V; Weller, M; Steinbach, J P (2012). Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial. Acta Neurochirurgica, 154(2):229-235.

Kober, C; Berg, B I; Sturmat, M; Rieger, J; Gallo, L M; Boel, M; Mack, M; Zeilhofer, H F; Sader, R (2012). Macroscopic muscular modeling based on in vivo 4D-radiology. International Journal of Multiscale Computing and Engineering, 10(2):131-142.

Burger, M C; Brucker, D P; Baumgarten, P; Ronellenfitsch, M W; Wanka, C; Hasselblatt, M; Eccles, M R; Klingebiel, T; Weller, M; Rieger, J; Mittelbronn, M; Steinbach, J P (2012). PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma. International Journal of Oncology, 41(1):235-241.

Wanka, C; Brucker, D P; Bähr, O; Ronellenfitsch, M; Weller, M; Steinbach, J P; Rieger, J (2012). Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death. Oncogene, 31(33):3764-3776.

Glas, M; Bähr, O; Felsberg, J; Rasch, K; Wiewrodt, D; Schabet, M; Simon, M; Urbach, H; Steinbach, J P; Rieger, J; Fimmers, R; Bamberg, M; Nägele, T; Reifenberger, G; Weller, M; Herrlinger, U (2011). NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri. Annals of Neurology, 70(3):445-53.

Glas, M; Happold, C; Rieger, J; Wiewrodt, D; Bähr, O; Steinbach, J P; Wick, W; Kortmann, R; Reifenberger, G; Weller, M; Herrlinger, U (2009). Long-term survival of glioblastoma patients treated with radiotherapy and lomustine plus temozolomide. Journal of Clinical Oncology, 27(8):1257-1261.

Ronellenfitsch, M W; Brucker, D P; Burger, M C; Wolking, S; Tritschler, F; Rieger, J; Wick, W; Weller, M; Steinbach, J P (2009). Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. Brain: A Journal of Neurology, 132(Pt 6):1509-1522.

Rieger, J; Lemke, D; Maurer, G; Weiler, M; Frank, B; Tabatabai, G; Weller, M; Wick, W (2008). Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. Journal of Neurochemistry, 106(6):2436-2448.

This list was generated on Wed Dec 13 00:25:30 2017 CET.